Chugai Pharmaceutical to dispose of treasury stock for compensation plan

Chugai Pharmaceutical (TSE:4519) announced it will dispose of 79,800 shares of its treasury stock to its directors, vice presidents, employees, and subsidiary personnel as part of a restricted stock compensation plan. The disposal, valued at JPY565,861,800, will take place on April 25, 2025, at a price of JPY7,091 per share. The plan aims to incentivize executives and employees, aligning their interests with shareholders and promoting sustainable corporate value. The stock will be subject to transfer restrictions until April 30, 2028, with specific conditions for release based on continued service and company performance against peers. Concurrently, Chugai is reviewing its investment unit, recognizing the potential for stock splits and other measures to broaden its investor base and improve liquidity, although a decision has not yet been made.